Target intelligence / Profile preview

Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 9 (UBA52P9)

Target
UBA52P9
Molecular classification
Other (pseudogene of ribosomal protein / ubiquitin fusion gene)
01

Overview

UBA52P9 is a **processed pseudogene** derived from the UBA52 gene, which normally encodes a fusion protein comprising ubiquitin and ribosomal protein L40[1][4][5]. The parent UBA52 gene plays essential roles in protein degradation and ribosome assembly in eukaryotic cells, but UBA52P9 itself does not encode a functional protein due to its pseudogene status[5][8]. The human genome contains many such processed pseudogenes of ribosomal proteins, which are generally considered non-functional remnants without known biological effects, although in rare cases pseudogenes can have regulatory roles at the RNA level[2]. There is no evidence UBA52P9 is involved in any disease, serves as a therapeutic target, or is of pharmacological interest.

Other names
RPL40_4_1591Ribosomal protein L40 pseudogeneUBA52P9
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, UBA52P9 is not known to encode a functional product in humans[1][5])
04

Disease associations

Other (no direct disease association for UBA52P9; however, some pseudogenes can have regulatory RNA functions, but this has not been demonstrated for UBA52P9 specifically[2][5][8])

Beyond the preview

Go deeper on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 9 (UBA52P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 9 (UBA52P9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call